Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Preliminary data presented on safety, PK and PD of PF-0538062 for hemophilia

July 14, 2015

Imbruvica approved in E.U. for Waldenstrom's macroglobulinemia

July 13, 2015

Idarucizumab rapidly and completely reverses anticoagulant effects of dabigatran in clinical trial

July 10, 2015

Daiichi Sankyo presents first-in-human results for DS-1040

July 9, 2015

Dyax's DX-2930 receives FDA breakthrough therapy designation

July 8, 2015

Acoalan approved in Japan

July 6, 2015

New study shows promising activity of LSD1 inhibitor RN-1 for sickle cell disease

July 6, 2015

Prolong's novel ANF compound for hematopoiesis deficiencies

July 2, 2015

FibroGen receives license payment from AstraZeneca for roxadustat

July 1, 2015

Bayer files for Japanese approval of BAY-81-8973 for hemophilia A

June 30, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
In monkeys, enhanced TB vaccine dissolves after inducing protection
BioWorld Science
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...